1.
Tex Heart Inst J
; 36(1): 74-5, 2009.
Article
in English
| MEDLINE
| ID: mdl-19436794
Subject(s)
Abnormalities, Multiple/diagnostic imaging , Heart Septal Defects, Atrial/diagnostic imaging , Heart Septal Defects, Ventricular/diagnostic imaging , Tomography, X-Ray Computed , Abnormalities, Multiple/surgery , Adult , Cardiac Surgical Procedures , Heart Septal Defects, Atrial/surgery , Heart Septal Defects, Ventricular/surgery , Heart Ventricles/abnormalities , Heart Ventricles/diagnostic imaging , Humans , Male , Predictive Value of Tests
2.
Tex Heart Inst J
; 36(6): 618-20, 2009.
Article
in English
| MEDLINE
| ID: mdl-20069095
ABSTRACT
Drug-eluting stents were developed and approved for the reduction of in-stent restenosis. However, restenosis still occurs, and stent fracture is suggested as a cause of restenosis after implantation. Although sirolimus-eluting stents are considered to carry a high risk of fracture, the risk is also present with other drug-eluting stents. Herein, we report the case of a 78-year-old woman who received a zotarolimus-eluting stent for a bifurcation lesion of the left anterior descending coronary artery. Ten months later, she underwent coronary angiography due to angina. The angiogram revealed in-stent restenosis, with a grade IV stent fracture. After percutaneous coronary angioplasty, the patient's clinical symptoms improved.